Berger Montague Reminds RxSight, Inc. (NASDAQ: RXST) Investors With Substantial Losses to Inquire About a Securities Fraud Class Action by September 22, 2025
RxSight(US:RXST) Prnewswire·2025-09-12 23:41Accessibility StatementSkip Navigation PHILADELPHIA, Sept. 12, 2025 /PRNewswire/ -- Berger Montague PCÂ is investigating potential securities fraud claims on behalf of investors in RxSight, Inc. ("RxSight" or the "Company") (NASDAQ: RXST). RxSight, headquartered in Aliso Viejo, CA, is a medical technology company that develops light adjustable intraocular lenses (LAL) used in cataract surgery. Its RxSight system involves the Company's Light Delivery Device (LDD). Caitlin AdorniBerger Montague(267) 764-4865[ ...